Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
82.5M
-
Shares change
-
+1.72M
-
Total reported value, excl. options
-
$1.62B
-
Value change
-
+$50.6M
-
Put/Call ratio
-
1.3
-
Number of buys
-
79
-
Number of sells
-
-58
-
Price
-
$19.63
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2020
167 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q4 2020.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.5M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (9.11M shares), MAVERICK CAPITAL LTD (7.32M shares), Redmile Group, LLC (6.86M shares), BlackRock Inc. (6.45M shares), JPMORGAN CHASE & CO (6.21M shares), VANGUARD GROUP INC (5.64M shares), MORGAN STANLEY (3.62M shares), Consonance Capital Management LP (3.53M shares), STATE STREET CORP (2.98M shares), and GOLDMAN SACHS GROUP INC (2.65M shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.